| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF597 TBX15 ZEB1 ZBTB7C FEZF2 NPAS3 ZNF343 MECOM POU3F1 ZNF880 ZBTB26 ZNF57 FOXA2 ZBTB7B TBX18 ZBTB7A SALL2 ZBTB32 ZNF550 FEZF1 NFIL3 ZKSCAN3 ZBTB21 PLAGL2 ZNF264 ZNF799 ZNF664 TBX20 ZNF439 PRDM15 ZNF443 ZNF426 ZNF513 TBX6 | 1.09e-15 | 1412 | 97 | 34 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF597 TBX15 ZEB1 ZBTB7C FEZF2 NPAS3 ZNF343 MECOM POU3F1 ZNF880 ZBTB26 ZNF57 FOXA2 ZBTB7B TBX18 ZBTB7A SALL2 ZBTB32 ZNF550 FEZF1 NFIL3 ZKSCAN3 ZNF264 ZNF799 ZNF664 TBX20 ZNF439 PRDM15 ZNF443 ZNF426 ZNF513 TBX6 | 1.31e-13 | 1459 | 97 | 32 | GO:0000977 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF597 TBX15 ZEB1 ZBTB7C FEZF2 MECOM POU3F1 ZNF880 ZBTB26 FOXA2 ZBTB7B TBX18 ZBTB7A SALL2 ZBTB32 FEZF1 NFIL3 ZKSCAN3 ZNF264 ZNF664 TBX20 PRDM15 ZNF426 ZNF513 TBX6 | 7.56e-10 | 1244 | 97 | 25 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF597 TBX15 ZEB1 ZBTB7C FEZF2 MECOM POU3F1 ZNF880 ZBTB26 FOXA2 ZBTB7B TBX18 ZBTB7A SALL2 ZBTB32 FEZF1 NFIL3 ZKSCAN3 ZNF264 ZNF664 TBX20 PRDM15 ZNF426 ZNF513 TBX6 | 1.18e-09 | 1271 | 97 | 25 | GO:0000987 |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | TBX15 ZEB1 FEZF2 POU3F1 ZBTB26 ZBTB7B TBX18 ZBTB7A ZBTB32 FEZF1 NFIL3 ZKSCAN3 ZBTB21 | 6.28e-09 | 326 | 97 | 13 | GO:0001217 |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | TBX15 ZEB1 FEZF2 POU3F1 ZBTB26 TBX18 ZBTB7A ZBTB32 FEZF1 NFIL3 ZKSCAN3 ZBTB21 | 4.93e-08 | 320 | 97 | 12 | GO:0001227 |
| GeneOntologyMolecularFunction | protein kinase activity | TRPM6 MAK TAOK2 BMX STRADA CLK3 TBCK RPS6KA6 MAPK6 MERTK MAP3K2 | 1.58e-04 | 600 | 97 | 11 | GO:0004672 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | TRPM6 MAK TAOK2 BMX STRADA CLK3 TBCK RPS6KA6 MAPK6 MERTK MAP3K2 | 6.50e-04 | 709 | 97 | 11 | GO:0016773 |
| GeneOntologyMolecularFunction | kinase activity | TRPM6 MAK TAOK2 BMX STRADA CLK3 TBCK RPS6KA6 MAPK6 MERTK MAP3K2 | 1.19e-03 | 764 | 97 | 11 | GO:0016301 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | 1.48e-03 | 446 | 97 | 8 | GO:0004674 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 1.61e-03 | 560 | 97 | 9 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 1.73e-03 | 566 | 97 | 9 | GO:0001216 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | TRPM6 MAK TAOK2 BMX STRADA CLK3 TBCK SELENOO RPS6KA6 MAPK6 MERTK MAP3K2 | 1.94e-03 | 938 | 97 | 12 | GO:0016772 |
| GeneOntologyMolecularFunction | protein serine kinase activity | 1.96e-03 | 363 | 97 | 7 | GO:0106310 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | TBX15 ZEB1 FEZF2 SHC1 MECOM POU3F1 ZBTB26 RUNX1T1 CBFA2T3 ZBTB7B TBX18 ZBTB7A SALL2 ZBTB32 FEZF1 NFIL3 ZKSCAN3 ZBTB21 TBX20 TBX6 | 6.57e-06 | 1399 | 97 | 20 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | TBX15 ZEB1 FEZF2 POU3F1 ZBTB26 CBFA2T3 ZBTB7B TBX18 ZBTB7A SALL2 ZBTB32 FEZF1 NFIL3 ZKSCAN3 ZBTB21 TBX20 TBX6 | 7.57e-06 | 1053 | 97 | 17 | GO:0000122 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | TBX15 ZEB1 FEZF2 SHC1 MECOM POU3F1 ZBTB26 RUNX1T1 CBFA2T3 ZBTB7B TBX18 ZBTB7A SALL2 ZBTB32 FEZF1 NFIL3 ZKSCAN3 ZBTB21 TBX20 TBX6 | 7.61e-06 | 1413 | 97 | 20 | GO:1902679 |
| GeneOntologyBiologicalProcess | cell fate specification | 2.52e-05 | 123 | 97 | 6 | GO:0001708 | |
| GeneOntologyBiologicalProcess | forebrain anterior/posterior pattern specification | 1.31e-04 | 4 | 97 | 2 | GO:0021797 | |
| GeneOntologyBiologicalProcess | anterior/posterior pattern specification | 1.67e-04 | 247 | 97 | 7 | GO:0009952 | |
| GeneOntologyBiologicalProcess | pattern specification process | 1.84e-04 | 526 | 97 | 10 | GO:0007389 | |
| GeneOntologyBiologicalProcess | axis specification | 1.95e-04 | 113 | 97 | 5 | GO:0009798 | |
| GeneOntologyBiologicalProcess | cell fate commitment | 1.95e-04 | 338 | 97 | 8 | GO:0045165 | |
| GeneOntologyBiologicalProcess | regulation of acinar cell proliferation | 2.17e-04 | 5 | 97 | 2 | GO:1904697 | |
| GeneOntologyBiologicalProcess | acinar cell proliferation | 2.17e-04 | 5 | 97 | 2 | GO:1990863 | |
| MousePheno | small intervertebral disk | 3.07e-05 | 2 | 78 | 2 | MP:0004682 | |
| MousePheno | abnormal vertebral articular process morphology | 3.07e-05 | 2 | 78 | 2 | MP:0004602 | |
| MousePheno | abnormal intervertebral disk morphology | 3.50e-05 | 67 | 78 | 5 | MP:0004173 | |
| MousePheno | abnormal symphysis morphology | 4.64e-05 | 71 | 78 | 5 | MP:0030877 | |
| MousePheno | abnormal cartilaginous joint morphology | 1.10e-04 | 85 | 78 | 5 | MP:0030875 | |
| Domain | - | ZNF597 ZEB1 ZBTB7C FEZF2 ZIM2 ZNF343 MECOM ZNF880 ZBTB26 ZNF57 ZNF285 ZBTB7B ZBTB7A ZNF800 SALL2 ZBTB32 ZNF550 FEZF1 ZKSCAN3 ZBTB21 PLAGL2 ZNF264 ZNF799 ZNF664 ZNF439 PRDM15 ZNF443 ZNF426 ZNF513 | 3.11e-19 | 679 | 96 | 29 | 3.30.160.60 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF597 ZEB1 ZBTB7C FEZF2 ZIM2 ZNF343 MECOM ZNF880 ZBTB26 ZNF57 ZNF285 ZBTB7B ZBTB7A ZNF800 SALL2 ZBTB32 ZNF550 FEZF1 ZKSCAN3 ZBTB21 PLAGL2 ZNF264 ZNF799 ZNF664 ZNF439 PRDM15 ZNF443 ZNF426 ZNF513 | 5.63e-19 | 694 | 96 | 29 | IPR013087 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF597 ZEB1 ZBTB7C FEZF2 APTX ZIM2 ZNF343 MECOM ZNF880 ZBTB26 ZNF57 ZNF285 ZBTB7B ZBTB7A ZNF800 SALL2 ZBTB32 ZNF550 FEZF1 ZKSCAN3 ZBTB21 PLAGL2 ZNF264 ZNF799 ZNF664 ZNF439 PRDM15 ZNF443 ZNF426 ZNF513 | 1.02e-18 | 775 | 96 | 30 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF597 ZEB1 ZBTB7C FEZF2 APTX ZIM2 ZNF343 MECOM ZNF880 ZBTB26 ZNF57 ZNF285 ZBTB7B ZBTB7A ZNF800 SALL2 ZBTB32 ZNF550 FEZF1 ZKSCAN3 ZBTB21 PLAGL2 ZNF264 ZNF799 ZNF664 ZNF439 PRDM15 ZNF443 ZNF426 ZNF513 | 1.10e-18 | 777 | 96 | 30 | PS00028 |
| Domain | Znf_C2H2-like | ZNF597 ZEB1 ZBTB7C FEZF2 APTX ZIM2 ZNF343 MECOM ZNF880 ZBTB26 ZNF57 ZNF285 ZBTB7B ZBTB7A ZNF800 SALL2 ZBTB32 ZNF550 FEZF1 ZKSCAN3 ZBTB21 PLAGL2 ZNF264 ZNF799 ZNF664 ZNF439 PRDM15 ZNF443 ZNF426 ZNF513 | 2.15e-18 | 796 | 96 | 30 | IPR015880 |
| Domain | Znf_C2H2 | ZNF597 ZEB1 ZBTB7C FEZF2 APTX ZIM2 ZNF343 MECOM ZNF880 ZBTB26 ZNF57 ZNF285 ZBTB7B ZBTB7A ZNF800 SALL2 ZBTB32 ZNF550 FEZF1 ZKSCAN3 ZBTB21 PLAGL2 ZNF264 ZNF799 ZNF664 ZNF439 PRDM15 ZNF443 ZNF426 ZNF513 | 2.93e-18 | 805 | 96 | 30 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF597 ZEB1 ZBTB7C FEZF2 APTX ZIM2 ZNF343 MECOM ZNF880 ZBTB26 ZNF57 ZNF285 ZBTB7B ZBTB7A ZNF800 SALL2 ZBTB32 ZNF550 FEZF1 ZKSCAN3 ZBTB21 PLAGL2 ZNF264 ZNF799 ZNF664 ZNF439 PRDM15 ZNF443 ZNF426 ZNF513 | 3.25e-18 | 808 | 96 | 30 | SM00355 |
| Domain | zf-C2H2 | ZNF597 ZBTB7C FEZF2 ZIM2 ZNF343 MECOM ZNF880 ZBTB26 ZNF57 ZNF285 ZBTB7B ZBTB7A SALL2 ZBTB32 ZNF550 FEZF1 ZKSCAN3 ZBTB21 PLAGL2 ZNF264 ZNF799 ZNF664 ZNF439 PRDM15 ZNF443 ZNF426 ZNF513 | 6.85e-17 | 693 | 96 | 27 | PF00096 |
| Domain | BTB | ANKFY1 KLHL28 ZBTB7C ZBTB26 ZBTB7B KLHL29 ZBTB7A ZBTB32 ZBTB21 | 2.41e-08 | 131 | 96 | 9 | PF00651 |
| Domain | KRAB | ZNF597 ZIM2 ZNF343 ZNF880 ZNF57 ZNF285 ZNF550 ZKSCAN3 ZNF264 ZNF799 ZNF439 ZNF443 ZNF426 | 3.65e-08 | 358 | 96 | 13 | PS50805 |
| Domain | KRAB | ZNF597 ZIM2 ZNF343 ZNF880 ZNF57 ZNF285 ZNF550 ZKSCAN3 ZNF264 ZNF799 ZNF439 ZNF443 ZNF426 | 3.65e-08 | 358 | 96 | 13 | PF01352 |
| Domain | KRAB | ZNF597 ZIM2 ZNF343 ZNF880 ZNF57 ZNF285 ZNF550 ZKSCAN3 ZNF264 ZNF799 ZNF439 ZNF443 ZNF426 | 5.21e-08 | 369 | 96 | 13 | SM00349 |
| Domain | KRAB | ZNF597 ZIM2 ZNF343 ZNF880 ZNF57 ZNF285 ZNF550 ZKSCAN3 ZNF264 ZNF799 ZNF439 ZNF443 ZNF426 | 5.37e-08 | 370 | 96 | 13 | IPR001909 |
| Domain | BTB | ANKFY1 KLHL28 ZBTB7C ZBTB26 ZBTB7B KLHL29 ZBTB7A ZBTB32 ZBTB21 | 1.36e-07 | 160 | 96 | 9 | PS50097 |
| Domain | BTB | ANKFY1 KLHL28 ZBTB7C ZBTB26 ZBTB7B KLHL29 ZBTB7A ZBTB32 ZBTB21 | 3.71e-07 | 180 | 96 | 9 | SM00225 |
| Domain | BTB/POZ_dom | ANKFY1 KLHL28 ZBTB7C ZBTB26 ZBTB7B KLHL29 ZBTB7A ZBTB32 ZBTB21 | 4.67e-07 | 185 | 96 | 9 | IPR000210 |
| Domain | SKP1/BTB/POZ | ANKFY1 KLHL28 ZBTB7C ZBTB26 ZBTB7B KLHL29 ZBTB7A ZBTB32 ZBTB21 | 5.59e-07 | 189 | 96 | 9 | IPR011333 |
| Domain | zf-C2H2_6 | ZNF597 FEZF2 MECOM ZNF880 SALL2 FEZF1 PLAGL2 ZNF799 ZNF439 ZNF443 ZNF426 | 6.30e-07 | 314 | 96 | 11 | PF13912 |
| Domain | TF_T-box | 1.48e-06 | 17 | 96 | 4 | IPR001699 | |
| Domain | TBOX | 1.48e-06 | 17 | 96 | 4 | SM00425 | |
| Domain | TF_T-box_CS | 1.48e-06 | 17 | 96 | 4 | IPR018186 | |
| Domain | - | 1.48e-06 | 17 | 96 | 4 | 2.60.40.820 | |
| Domain | TBOX_3 | 1.48e-06 | 17 | 96 | 4 | PS50252 | |
| Domain | T-box | 1.48e-06 | 17 | 96 | 4 | PF00907 | |
| Domain | TBOX_1 | 1.48e-06 | 17 | 96 | 4 | PS01283 | |
| Domain | TBOX_2 | 1.48e-06 | 17 | 96 | 4 | PS01264 | |
| Domain | NHR2 | 7.82e-05 | 3 | 96 | 2 | IPR014896 | |
| Domain | NHR2 | 7.82e-05 | 3 | 96 | 2 | PF08788 | |
| Domain | CBFA2T1/2/3 | 7.82e-05 | 3 | 96 | 2 | IPR013289 | |
| Domain | Kinase-like_dom | TRPM6 MAK TAOK2 BMX STRADA CLK3 TBCK RPS6KA6 MAPK6 MERTK MAP3K2 | 1.05e-04 | 542 | 96 | 11 | IPR011009 |
| Domain | p53-like_TF_DNA-bd | 1.58e-04 | 53 | 96 | 4 | IPR008967 | |
| Domain | Prot_kinase_dom | 2.08e-04 | 489 | 96 | 10 | IPR000719 | |
| Domain | PROTEIN_KINASE_DOM | 2.22e-04 | 493 | 96 | 10 | PS50011 | |
| Domain | TAFH | 2.59e-04 | 5 | 96 | 2 | SM00549 | |
| Domain | TAFH | 2.59e-04 | 5 | 96 | 2 | PS51119 | |
| Domain | TAFH | 2.59e-04 | 5 | 96 | 2 | PF07531 | |
| Domain | TAFH_NHR1 | 2.59e-04 | 5 | 96 | 2 | IPR003894 | |
| Domain | TF_Brachyury | 3.87e-04 | 6 | 96 | 2 | IPR002070 | |
| Domain | Protein_kinase_ATP_BS | 7.49e-04 | 379 | 96 | 8 | IPR017441 | |
| Domain | Pkinase | 7.75e-04 | 381 | 96 | 8 | PF00069 | |
| Domain | Roc | 1.97e-03 | 13 | 96 | 2 | PF08477 | |
| Domain | MIRO-like | 1.97e-03 | 13 | 96 | 2 | IPR013684 | |
| Domain | CYTOCHROME_B5_2 | 1.97e-03 | 13 | 96 | 2 | PS50255 | |
| Domain | CYTOCHROME_B5_1 | 1.97e-03 | 13 | 96 | 2 | PS00191 | |
| Domain | Dynein_HC_stalk | 2.29e-03 | 14 | 96 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 2.29e-03 | 14 | 96 | 2 | IPR013602 | |
| Domain | DHC_N2 | 2.29e-03 | 14 | 96 | 2 | PF08393 | |
| Domain | MT | 2.29e-03 | 14 | 96 | 2 | PF12777 | |
| Domain | Cyt-b5 | 2.29e-03 | 14 | 96 | 2 | PF00173 | |
| Domain | Cyt_B5-like_heme/steroid-bd | 2.29e-03 | 14 | 96 | 2 | IPR001199 | |
| Domain | Cyt-b5 | 2.29e-03 | 14 | 96 | 2 | SM01117 | |
| Domain | - | 2.29e-03 | 14 | 96 | 2 | 3.10.120.10 | |
| Domain | PROTEIN_KINASE_ATP | 2.51e-03 | 459 | 96 | 8 | PS00107 | |
| Domain | DHC_fam | 2.63e-03 | 15 | 96 | 2 | IPR026983 | |
| Domain | Dynein_heavy_dom | 2.63e-03 | 15 | 96 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 2.63e-03 | 15 | 96 | 2 | PF03028 | |
| Domain | Kelch | 3.31e-03 | 58 | 96 | 3 | SM00612 | |
| Domain | Gal_Oxase/kelch_b-propeller | 3.47e-03 | 59 | 96 | 3 | IPR011043 | |
| Pubmed | 2.56e-08 | 63 | 98 | 6 | 34351428 | ||
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | ZNF597 TBX15 ZNF343 POU3F1 ZBTB26 FOXA2 ZBTB7B TBX18 ZBTB7A ZBTB32 TBX20 TBX6 | 4.56e-08 | 544 | 98 | 12 | 28473536 |
| Pubmed | TBX15 ZEB1 ANKFY1 POU3F1 BRD3 ZBTB7B ZBTB7A NFIL3 ZKSCAN3 ZBTB21 PLAGL2 TBX20 ZNF426 ZNF513 | 6.42e-08 | 808 | 98 | 14 | 20412781 | |
| Pubmed | 8.66e-08 | 4 | 98 | 3 | 20832395 | ||
| Pubmed | The zinc finger transcription factor Th-POK regulates CD4 versus CD8 T-cell lineage commitment. | 2.16e-07 | 5 | 98 | 3 | 15729333 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | TBX15 ZEB1 NPAS3 POU3F1 FOXA2 ZBTB7B TBX18 ZBTB7A SALL2 NFIL3 PLAGL2 TBX20 TBX6 | 1.67e-06 | 908 | 98 | 13 | 19274049 |
| Pubmed | 2.28e-06 | 33 | 98 | 4 | 18356246 | ||
| Pubmed | FASTKD2 LRCH1 NPLOC4 TAOK2 ZBTB21 ANKIB1 PLAGL2 CEP126 MTREX AGAP1 | 2.58e-06 | 529 | 98 | 10 | 14621295 | |
| Pubmed | 2.94e-06 | 418 | 98 | 9 | 34709266 | ||
| Pubmed | Transcriptional repression by the T-box proteins Tbx18 and Tbx15 depends on Groucho corepressors. | 3.52e-06 | 11 | 98 | 3 | 17584735 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 20152183 | ||
| Pubmed | Deletion of the endothelial Bmx tyrosine kinase decreases tumor angiogenesis and growth. | 7.86e-06 | 2 | 98 | 2 | 22593188 | |
| Pubmed | The hcKrox gene family regulates multiple extracellular matrix genes. | 7.86e-06 | 2 | 98 | 2 | 11691585 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 24913420 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 28245922 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 33627571 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 16314561 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 10022820 | ||
| Pubmed | 1.18e-05 | 16 | 98 | 3 | 21350012 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | PATL1 CPT1A NPLOC4 KLHL29 ZBTB7A DPP9 KIAA1217 TBCK KCNMA1 ANKIB1 MAPK6 PLOD1 PRDM15 AGAP1 AGAP3 | 1.79e-05 | 1489 | 98 | 15 | 28611215 |
| Pubmed | 1.89e-05 | 402 | 98 | 8 | 24722188 | ||
| Pubmed | 2.03e-05 | 19 | 98 | 3 | 32156757 | ||
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 21527937 | ||
| Pubmed | CBFA2T1, a gene rearranged in human leukemia, is a member of a multigene family. | 2.35e-05 | 3 | 98 | 2 | 9790752 | |
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 31827238 | ||
| Pubmed | Myeloid translocation genes differentially regulate colorectal cancer programs. | 2.35e-05 | 3 | 98 | 2 | 27270437 | |
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 38243303 | ||
| Pubmed | Targeting BRD3 eradicates nuclear TYRO3-induced colorectal cancer metastasis. | 2.35e-05 | 3 | 98 | 2 | 37043564 | |
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 26968532 | ||
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 22080605 | ||
| Pubmed | Zinc finger protein 277 is an intestinal transit-amplifying cell marker and colon cancer oncogene. | 2.35e-05 | 3 | 98 | 2 | 35015732 | |
| Pubmed | ZBTB7A mutations in acute myeloid leukaemia with t(8;21) translocation. | 2.35e-05 | 3 | 98 | 2 | 27252013 | |
| Pubmed | Targeted disruption of Fgf8 causes failure of cell migration in the gastrulating mouse embryo. | 2.78e-05 | 21 | 98 | 3 | 10421635 | |
| Pubmed | 3.69e-05 | 23 | 98 | 3 | 20089898 | ||
| Pubmed | 3.74e-05 | 132 | 98 | 5 | 34321664 | ||
| Pubmed | 3.95e-05 | 446 | 98 | 8 | 24255178 | ||
| Pubmed | 4.70e-05 | 4 | 98 | 2 | 9888994 | ||
| Pubmed | 4.70e-05 | 4 | 98 | 2 | 23988578 | ||
| Pubmed | 4.70e-05 | 4 | 98 | 2 | 29895619 | ||
| Pubmed | Selective role of a distinct tyrosine residue on Tie2 in heart development and early hematopoiesis. | 4.70e-05 | 4 | 98 | 2 | 15899871 | |
| Pubmed | Interactions between the leukaemia-associated ETO homologues of nuclear repressor proteins. | 4.70e-05 | 4 | 98 | 2 | 14703694 | |
| Pubmed | 4.70e-05 | 4 | 98 | 2 | 16966434 | ||
| Pubmed | 4.70e-05 | 4 | 98 | 2 | 16677630 | ||
| Pubmed | 4.70e-05 | 4 | 98 | 2 | 24104551 | ||
| Pubmed | A STAT3-dependent transcriptional circuitry inhibits cytotoxic gene expression in T cells. | 4.70e-05 | 4 | 98 | 2 | 29180433 | |
| Pubmed | Crucial role for Mst1 and Mst2 kinases in early embryonic development of the mouse. | 4.77e-05 | 25 | 98 | 3 | 19786569 | |
| Pubmed | 5.38e-05 | 26 | 98 | 3 | 26493106 | ||
| Pubmed | Tbx20 is essential for cardiac chamber differentiation and repression of Tbx2. | 6.75e-05 | 28 | 98 | 3 | 15901664 | |
| Pubmed | Critical role of phosphodiesterase 2A in mouse congenital heart defects. | 6.75e-05 | 28 | 98 | 3 | 29409032 | |
| Pubmed | 7.82e-05 | 5 | 98 | 2 | 18849530 | ||
| Pubmed | Regional expression of MTG genes in the developing mouse central nervous system. | 7.82e-05 | 5 | 98 | 2 | 19618476 | |
| Pubmed | 7.82e-05 | 5 | 98 | 2 | 18586123 | ||
| Pubmed | 7.82e-05 | 5 | 98 | 2 | 22025255 | ||
| Pubmed | 7.82e-05 | 5 | 98 | 2 | 21804610 | ||
| Pubmed | 7.82e-05 | 5 | 98 | 2 | 11416142 | ||
| Pubmed | 7.82e-05 | 5 | 98 | 2 | 9724649 | ||
| Pubmed | 7.82e-05 | 5 | 98 | 2 | 23041065 | ||
| Pubmed | 7.82e-05 | 5 | 98 | 2 | 18039847 | ||
| Pubmed | A Tgfbr1/Snai1-dependent developmental module at the core of vertebrate axial elongation. | 8.33e-05 | 30 | 98 | 3 | 32597756 | |
| Pubmed | ER71 acts downstream of BMP, Notch, and Wnt signaling in blood and vessel progenitor specification. | 8.33e-05 | 30 | 98 | 3 | 18462699 | |
| Pubmed | Temporal patterning of apical progenitors and their daughter neurons in the developing neocortex. | 8.76e-05 | 82 | 98 | 4 | 31073041 | |
| Pubmed | 1.01e-04 | 32 | 98 | 3 | 38110169 | ||
| Pubmed | MLL4 is required after implantation, whereas MLL3 becomes essential during late gestation. | 1.11e-04 | 33 | 98 | 3 | 32439762 | |
| Pubmed | Control of Regulatory T Cell Differentiation by the Transcription Factors Thpok and LRF. | 1.17e-04 | 6 | 98 | 2 | 28754678 | |
| Pubmed | Independent origins of fetal liver haematopoietic stem and progenitor cells. | 1.17e-04 | 6 | 98 | 2 | 36104564 | |
| Pubmed | 1.17e-04 | 6 | 98 | 2 | 22121118 | ||
| Pubmed | Kaiso directs the transcriptional corepressor MTG16 to the Kaiso binding site in target promoters. | 1.17e-04 | 6 | 98 | 2 | 23251453 | |
| Pubmed | Mapping Wnt/beta-catenin signaling during mouse development and in colorectal tumors. | 1.17e-04 | 6 | 98 | 2 | 12626757 | |
| Pubmed | 1.17e-04 | 6 | 98 | 2 | 35075245 | ||
| Pubmed | High-fat diet-activated fatty acid oxidation mediates intestinal stemness and tumorigenicity. | 1.17e-04 | 6 | 98 | 2 | 34107251 | |
| Pubmed | 1.17e-04 | 6 | 98 | 2 | 25129370 | ||
| Pubmed | 1.45e-04 | 36 | 98 | 3 | 18094027 | ||
| Pubmed | 1.46e-04 | 689 | 98 | 9 | 36543142 | ||
| Pubmed | Ezh2 restricts the smooth muscle lineage during mouse lung mesothelial development. | 1.64e-04 | 7 | 98 | 2 | 27578795 | |
| Pubmed | 1.64e-04 | 7 | 98 | 2 | 28926609 | ||
| Pubmed | Primate gastrulation and early organogenesis at single-cell resolution. | 1.64e-04 | 7 | 98 | 2 | 36517595 | |
| Pubmed | 1.64e-04 | 7 | 98 | 2 | 17478445 | ||
| Pubmed | A UAF1-containing multisubunit protein complex regulates the Fanconi anemia pathway. | 1.64e-04 | 7 | 98 | 2 | 18082604 | |
| Pubmed | 1.64e-04 | 7 | 98 | 2 | 23467409 | ||
| Pubmed | 1.64e-04 | 7 | 98 | 2 | 11528125 | ||
| Pubmed | 1.64e-04 | 7 | 98 | 2 | 12242670 | ||
| Pubmed | 1.66e-04 | 181 | 98 | 5 | 37372979 | ||
| Pubmed | 1.81e-04 | 709 | 98 | 9 | 22988430 | ||
| Pubmed | Transcriptional network orchestrating regional patterning of cortical progenitors. | 1.84e-04 | 39 | 98 | 3 | 34921112 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | ZNF597 TBX15 APC RUNX1T1 ZBTB7B TBX18 ZBTB32 PLAGL2 TBX20 ZNF513 | 1.87e-04 | 877 | 98 | 10 | 20211142 |
| Pubmed | 2.12e-04 | 103 | 98 | 4 | 10574462 | ||
| Pubmed | 2.13e-04 | 191 | 98 | 5 | 24146773 | ||
| Pubmed | 2.14e-04 | 41 | 98 | 3 | 25810521 | ||
| Pubmed | 2.18e-04 | 8 | 98 | 2 | 34124060 | ||
| Pubmed | Lack of protein S in mice causes embryonic lethal coagulopathy and vascular dysgenesis. | 2.18e-04 | 8 | 98 | 2 | 19729839 | |
| Pubmed | 2.18e-04 | 8 | 98 | 2 | 22558218 | ||
| Pubmed | 2.18e-04 | 8 | 98 | 2 | 11533236 | ||
| Pubmed | 2.18e-04 | 8 | 98 | 2 | 17117439 | ||
| Pubmed | The ShcA phosphotyrosine docking protein sensitizes cardiovascular signaling in the mouse embryo. | 2.18e-04 | 8 | 98 | 2 | 10809671 | |
| Pubmed | Developmental origin of age-related coronary artery disease. | 2.18e-04 | 8 | 98 | 2 | 26054850 | |
| Pubmed | Extracardiac control of embryonic cardiomyocyte proliferation and ventricular wall expansion. | 2.18e-04 | 8 | 98 | 2 | 25560321 | |
| Pubmed | The orphan steroid receptor Nur77 family member Nor-1 is essential for early mouse embryogenesis. | 2.18e-04 | 8 | 98 | 2 | 13129926 | |
| Pubmed | 2.18e-04 | 8 | 98 | 2 | 19956724 | ||
| Pubmed | 2.18e-04 | 8 | 98 | 2 | 22164283 | ||
| Pubmed | 2.30e-04 | 42 | 98 | 3 | 34673265 | ||
| Interaction | ZBTB7C interactions | 3.60e-06 | 22 | 98 | 4 | int:ZBTB7C | |
| Cytoband | 19p13.2 | 1.51e-03 | 229 | 98 | 4 | 19p13.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 1.64e-03 | 797 | 98 | 7 | chr19p13 | |
| Cytoband | 17q23.3 | 1.89e-03 | 30 | 98 | 2 | 17q23.3 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF597 ZEB1 ZBTB7C FEZF2 ZIM2 ZNF343 MECOM ZNF880 ZBTB26 ZNF57 ZNF285 ZBTB7B ZBTB7A ZNF800 SALL2 ZBTB32 ZNF550 FEZF1 ZKSCAN3 ZBTB21 PLAGL2 ZNF264 ZNF799 ZNF664 ZNF439 PRDM15 ZNF443 ZNF426 ZNF513 | 2.93e-21 | 718 | 77 | 29 | 28 |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | ANKFY1 KLHL28 ZBTB7C ZBTB26 ZBTB7B KLHL29 ZBTB7A ZBTB32 ZBTB21 | 5.42e-09 | 134 | 77 | 9 | 861 |
| GeneFamily | T-boxes | 8.89e-07 | 18 | 77 | 4 | 766 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 2.34e-03 | 17 | 77 | 2 | 1291 | |
| GeneFamily | Zinc fingers C2H2-type|PR/SET domain family | 2.34e-03 | 17 | 77 | 2 | 1197 | |
| GeneFamily | Zinc fingers MYND-type | 3.57e-03 | 21 | 77 | 2 | 87 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 4.65e-03 | 24 | 77 | 2 | 654 | |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | TBX15 POMT2 SHC1 ZIM2 FASTKD2 ZNF57 KLHL29 KIAA1217 KCNMA1 ZNF264 MAPK6 MTREX ZNF664 AGAP1 MAP3K2 | 5.02e-06 | 1009 | 98 | 15 | M157 |
| Coexpression | LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE | 1.35e-05 | 208 | 98 | 7 | M39233 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.03e-07 | 200 | 98 | 7 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | COVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.83e-06 | 179 | 98 | 6 | 2a53d94f6c30bf887dfe88f1693ea057218c852d | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(other)|COVID-19 / group, cell type (main and fine annotations) | 3.02e-06 | 181 | 98 | 6 | 26eb4ee57a70dbf54e096b73129fda9dfda1f6ec | |
| ToppCell | COVID-19-Heart-EC_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.22e-06 | 183 | 98 | 6 | ff95382cfed592190d0636d2b750328471f82e0d | |
| ToppCell | COVID-19-kidney-DCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.76e-06 | 188 | 98 | 6 | 1d56cd409793f05cca20757ab26e91f1a1ee67b5 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.76e-06 | 188 | 98 | 6 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | COVID-19-Endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 4.00e-06 | 190 | 98 | 6 | 9fbd92cd6d4683b2490504d29c43cf42020433d4 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-AEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.12e-06 | 191 | 98 | 6 | 50601ef0a5a8f2c2120922989e08e85bf2d9b4ab | |
| ToppCell | Control-Endothelial-VE_Capillary_B|World / Disease state, Lineage and Cell class | 4.12e-06 | 191 | 98 | 6 | c672c8e28d06d555335976b3f8bd2ea6d3b34aae | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.78e-06 | 196 | 98 | 6 | 49cc0a2b9739abad61dff7292ea0b14d28ff35c4 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.78e-06 | 196 | 98 | 6 | 686533fd3fba8e4df96b9dd1307e870e89db4332 | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type | 4.78e-06 | 196 | 98 | 6 | 4ac4073380d939a73cec7413e9f3f5ef616d2924 | |
| ToppCell | COVID-19-lung-Capillary_1|lung / Disease (COVID-19 only), tissue and cell type | 4.92e-06 | 197 | 98 | 6 | 7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4 | |
| ToppCell | nucseq-Endothelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.92e-06 | 197 | 98 | 6 | ebf9be068eaa658493fa7884fd19f34642922acb | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.21e-06 | 199 | 98 | 6 | 3835452e4848d7f7dd8651c17b746b271ef39688 | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.21e-06 | 199 | 98 | 6 | 9c2db0bb94cba71a3cc1827844da090e213e0258 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 5.36e-06 | 200 | 98 | 6 | edb64556b3fefe3144f73b6efe23b9ffd34091d2 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.36e-06 | 200 | 98 | 6 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.36e-06 | 200 | 98 | 6 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.22e-05 | 165 | 98 | 5 | 62457b7b74c6eae42d91d65e7dc6df6bf8e061f7 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.31e-05 | 166 | 98 | 5 | 9d4b44eb56ad38c26aed73444edf389abca6bdf6 | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-05 | 168 | 98 | 5 | 06dc5b2d356d3a9454b10bba6f3b9ead2a0a7d46 | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-05 | 168 | 98 | 5 | 1002f058a340763e3d8de0bd1f0547a903526ec6 | |
| ToppCell | 3'_v3-bone_marrow-Mast-Mast_cell_lympho|bone_marrow / Manually curated celltypes from each tissue | 3.71e-05 | 170 | 98 | 5 | 4dedf482cd4521b3f87d2b5ae80f7a3ea8686a15 | |
| ToppCell | COVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 5.00e-05 | 181 | 98 | 5 | c5f9c92af1384d9089c65afdf41c6feb8345a3ae | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.27e-05 | 183 | 98 | 5 | fc9a7ba148c22d0c8a46f6bc56c772929ac496f7 | |
| ToppCell | COVID-19-Endothelial_cells-Arterial_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 5.41e-05 | 184 | 98 | 5 | 0f19494789f38ab1a420545e15e748ca7eb345c3 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.55e-05 | 185 | 98 | 5 | 7dcdc009c5681ee05dd18968f7e85c3403fe34af | |
| ToppCell | Control-Endothelial-VE_Capillary_A|World / Disease state, Lineage and Cell class | 5.55e-05 | 185 | 98 | 5 | a28187c2fd23564314b35759479ff2ca21f61485 | |
| ToppCell | Control-Endothelial-Endothelial-Artery|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.69e-05 | 186 | 98 | 5 | 2d3a975d2bf92e18e3410dd413fc9f84831d82de | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.69e-05 | 186 | 98 | 5 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.84e-05 | 187 | 98 | 5 | 85f1678338a47d91e296f0620d4887f057eb7e70 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.84e-05 | 187 | 98 | 5 | e35716f8b482be3bf5ab79f087a9caf67a9d197a | |
| ToppCell | COVID-19-Endothelial_cells-Pulmonary_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 5.84e-05 | 187 | 98 | 5 | 2d20193a6cacdfa4877457c97b0077408942186c | |
| ToppCell | pdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.84e-05 | 187 | 98 | 5 | 7e376831a11ee72ed87abcdac631ca46ae29c250 | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D175|Adult / Lineage, Cell type, age group and donor | 5.84e-05 | 187 | 98 | 5 | f3548817f2fded5978137bb252cb628ac199e4f6 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.84e-05 | 187 | 98 | 5 | b827d9da7032bf051756ddf88352af922eb0f87b | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.84e-05 | 187 | 98 | 5 | 61c00604dda8b36a5c3eea6554e5601aa1b884f7 | |
| ToppCell | Control-Endothelial-VE_Capillary_A|Control / Disease state, Lineage and Cell class | 5.84e-05 | 187 | 98 | 5 | 54d7588172ac145ff5045ad9771636729ca3f0ca | |
| ToppCell | Control-Endothelial_cells-Arterial_endothelial_cells|Control / group, cell type (main and fine annotations) | 5.84e-05 | 187 | 98 | 5 | 81affaab3fe3e1daea45ada6445e906ddd33950e | |
| ToppCell | P07-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.99e-05 | 188 | 98 | 5 | 5bc1537e079c7435196c163bff5f639ea392a33a | |
| ToppCell | COVID-19-lung-Artery_EC|lung / Disease (COVID-19 only), tissue and cell type | 5.99e-05 | 188 | 98 | 5 | eecd7482b3c97d7f49993cb17edfab30c61232fc | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.99e-05 | 188 | 98 | 5 | ce85a56ac27a6432421dde93a1bafa8b943244b9 | |
| ToppCell | COPD-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 5.99e-05 | 188 | 98 | 5 | 1aa0e35b1c28ac847886fece16c3ef7fc6fcdd51 | |
| ToppCell | Endothelial-endothelial_cell_of_artery|World / Lineage, Cell type, age group and donor | 6.14e-05 | 189 | 98 | 5 | fdd89c71113ac99b7c800c6def8888e512ff1128 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.14e-05 | 189 | 98 | 5 | 7346c1112e2e155dbd71b6dbc80e680fd262a691 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 6.14e-05 | 189 | 98 | 5 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(general)|COVID-19 / group, cell type (main and fine annotations) | 6.30e-05 | 190 | 98 | 5 | 812e11314c76c0179fbe5a9bea29b41ce5cbc93d | |
| ToppCell | COVID-19-lung-Artery_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.30e-05 | 190 | 98 | 5 | 07b675befcd1d0a9c90cb17b5d22323468325d51 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.30e-05 | 190 | 98 | 5 | aed65d584ca0c25f6a8313c66b421a6618af82ea | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.30e-05 | 190 | 98 | 5 | 0e9847d7f49b2236b8a191e1a7df37556351ba9e | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.30e-05 | 190 | 98 | 5 | f6c38d197fd9d69a4f97cb2e72cd4747984c1a86 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.45e-05 | 191 | 98 | 5 | f229abf69a1217194f74b0502486907e07dba989 | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Control / Disease state, Lineage and Cell class | 6.45e-05 | 191 | 98 | 5 | 322237793a1278bafb14e63cab688b353e352dcc | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.61e-05 | 192 | 98 | 5 | 1ee4783051ec94ea94600f040edcb385fc4289f1 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.61e-05 | 192 | 98 | 5 | c618ede75dce3988c87a5b8f98d8e94e1dd66efd | |
| ToppCell | PBMC-Severe-cDC_0|Severe / Compartment, Disease Groups and Clusters | 6.61e-05 | 192 | 98 | 5 | 4f4774b925058191673b4ba4b4d05b8b37f61795 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 6.61e-05 | 192 | 98 | 5 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.78e-05 | 193 | 98 | 5 | f582e939e3e08a8a3f71deec78c33715be8faa51 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.78e-05 | 193 | 98 | 5 | 02f633b016ab19bfa65bfd0cf32f000549a62148 | |
| ToppCell | LPS-antiTNF-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.78e-05 | 193 | 98 | 5 | 5122b1ffba42de190061be34ecdc6176f84e56a3 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.78e-05 | 193 | 98 | 5 | ad2df9b77999780860141be6ec366afc0172a331 | |
| ToppCell | COVID-19-Endothelial_cells-Inflamed_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 6.78e-05 | 193 | 98 | 5 | 979ebefa527f86bebeea5d94e626ee6c1cc7d53b | |
| ToppCell | Control-Endothelial-VE_Arterial|World / Disease state, Lineage and Cell class | 6.78e-05 | 193 | 98 | 5 | 52c0f2c7af57436f23e0c0e0c87086c47695e2c4 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.78e-05 | 193 | 98 | 5 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.78e-05 | 193 | 98 | 5 | ad3f4fcc8e2816d696cbcde744dc16500e51ccac | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.95e-05 | 194 | 98 | 5 | c5e77650d7abee339ec38fa78a622bb124db3fa5 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.95e-05 | 194 | 98 | 5 | 71ac69cdf7a08ca3ddfb5b492b14ac56b6cd5e5d | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.95e-05 | 194 | 98 | 5 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.95e-05 | 194 | 98 | 5 | 68004855b23fe1e31e8452d70effabc78a4a0bd3 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.95e-05 | 194 | 98 | 5 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.95e-05 | 194 | 98 | 5 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.95e-05 | 194 | 98 | 5 | b490fffc94f005dff9a34ce34d80ca776e3a1387 | |
| ToppCell | Adult-Endothelial|Adult / Lineage, Cell type, age group and donor | 6.95e-05 | 194 | 98 | 5 | 963b3fbee0575af8379baa397ace65949eaf34f7 | |
| ToppCell | Control-Endothelial|Control / Disease state, Lineage and Cell class | 6.95e-05 | 194 | 98 | 5 | 485fe5538fabec457b9a51feb641f2a91cbf4e18 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 7.12e-05 | 195 | 98 | 5 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-05 | 195 | 98 | 5 | df644b4c3ddccd34614ece5a2378000e6bc0fa10 | |
| ToppCell | Control-Endothelial-VE_Arterial|Control / Disease state, Lineage and Cell class | 7.12e-05 | 195 | 98 | 5 | 56c66a3655820961e1390b8f4bcc5618e8d0c5a8 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.12e-05 | 195 | 98 | 5 | 023e3c97dd3696d74f002ff8da0c04d876c82aef | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 7.12e-05 | 195 | 98 | 5 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | Children_(3_yrs)-Endothelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.12e-05 | 195 | 98 | 5 | 094cf6591daa5ffad36e44122b6f524a3a34c2fd | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.29e-05 | 196 | 98 | 5 | cf7f384c1771274e766bab03ecc3dfbd13f2df60 | |
| ToppCell | Endothelial|World / Lineage, Cell type, age group and donor | 7.29e-05 | 196 | 98 | 5 | 96c6d78482a130ce4e29f6629972a06d10d7530e | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.47e-05 | 197 | 98 | 5 | cfb3dc4b401800e33c82cfc3baee69dbbd16ac8c | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.47e-05 | 197 | 98 | 5 | 107cb153ea7fc74bbd244dbb9d0499c0a8506724 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.47e-05 | 197 | 98 | 5 | 6a3c647af41fea923311562575a0d656fbc13cbe | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Duct|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.65e-05 | 198 | 98 | 5 | 1fe60443c11d34b6d2671af8f06e0dedc8d1558b | |
| ToppCell | COVID-19-lung-Capillary_2|lung / Disease (COVID-19 only), tissue and cell type | 7.83e-05 | 199 | 98 | 5 | 793ce71b78a68033ef4419ed571e1dd86b40124f | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.02e-05 | 200 | 98 | 5 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 8.02e-05 | 200 | 98 | 5 | 6f531a418ff25b59a543800cf4bce7b72404ce08 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 8.02e-05 | 200 | 98 | 5 | eb94a5111ef0e903ee5be9f7efe571b4e6d5fce1 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.02e-05 | 200 | 98 | 5 | a4ec0e80f5422b91b85264a9bb74568dd577e285 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.02e-05 | 200 | 98 | 5 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 8.02e-05 | 200 | 98 | 5 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_only / Treatment groups by lineage, cell group, cell type | 8.02e-05 | 200 | 98 | 5 | b1fadb2b5e37e0f51e079d8409c2647eef68dc3b | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-T/NK-dn_T|Int-URO / Disease, condition lineage and cell class | 8.02e-05 | 200 | 98 | 5 | 020439d9e70fff7246650ab0e9105236688c3ec3 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Artery|Control_saline / Treatment groups by lineage, cell group, cell type | 8.02e-05 | 200 | 98 | 5 | 65b71f1e8da5c3750fcd0a2e66d9ef3125a3f78a | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.02e-05 | 200 | 98 | 5 | f15fffefe372005c33e31845982e2d2714ac26af | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Otx2_(ventral_lateral_geniculate_nucleus,_magnocellular_part_(VLGMC)?)--|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 8.55e-05 | 105 | 98 | 4 | c7528276fee8f6d2cb4639069bc87413b0288025 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Otx2_(ventral_lateral_geniculate_nucleus,_magnocellular_part_(VLGMC)?)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 8.55e-05 | 105 | 98 | 4 | 7bcf3345a21a1ade717128be127e9fe12ae40011 | |
| Drug | Bupropion hydrochloride [31677-93-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 2.29e-06 | 198 | 98 | 8 | 6256_DN | |
| Disease | Large cell carcinoma of lung | 3.53e-06 | 32 | 96 | 4 | C0345958 | |
| Disease | phosphatidylcholine (16:0/22:5n3, 18:1/20:4) measurement | 1.04e-04 | 5 | 96 | 2 | EFO_0800467 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 1.26e-04 | 148 | 96 | 5 | C0279702 | |
| Disease | osteoarthritis, knee, body mass index | 3.25e-04 | 41 | 96 | 3 | EFO_0004340, EFO_0004616 | |
| Disease | diastolic blood pressure, systolic blood pressure | 3.40e-04 | 670 | 96 | 9 | EFO_0006335, EFO_0006336 | |
| Disease | Childhood Medulloblastoma | 3.75e-04 | 43 | 96 | 3 | C0278510 | |
| Disease | Melanotic medulloblastoma | 3.75e-04 | 43 | 96 | 3 | C1275668 | |
| Disease | Medullomyoblastoma | 3.75e-04 | 43 | 96 | 3 | C0205833 | |
| Disease | Desmoplastic Medulloblastoma | 3.75e-04 | 43 | 96 | 3 | C0751291 | |
| Disease | Adult Medulloblastoma | 3.75e-04 | 43 | 96 | 3 | C0278876 | |
| Disease | cortical surface area measurement | TRPM6 NPAS3 APC ARHGEF12 MECOM RUNX1T1 LRCH1 NPLOC4 KLHL29 MAPK6 AGAP1 AGAP3 TBX6 | 4.14e-04 | 1345 | 96 | 13 | EFO_0010736 |
| Disease | trypsin-3 measurement | 5.65e-04 | 11 | 96 | 2 | EFO_0020791 | |
| Disease | level of Sterol ester (27:1/20:5) in blood serum | 5.65e-04 | 11 | 96 | 2 | OBA_2045197 | |
| Disease | Medulloblastoma | 5.85e-04 | 50 | 96 | 3 | C0025149 | |
| Disease | Squamous cell carcinoma of the head and neck | 6.57e-04 | 52 | 96 | 3 | C1168401 | |
| Disease | arachidonoylcarnitine (C20:4) measurement | 6.77e-04 | 12 | 96 | 2 | EFO_0800544 | |
| Disease | anemia (implicated_via_orthology) | 1.07e-03 | 15 | 96 | 2 | DOID:2355 (implicated_via_orthology) | |
| Disease | Polyposis, Adenomatous Intestinal | 1.22e-03 | 16 | 96 | 2 | C2713442 | |
| Disease | Familial Intestinal Polyposis | 1.22e-03 | 16 | 96 | 2 | C2713443 | |
| Disease | Adenomatous Polyposis Coli | 1.38e-03 | 17 | 96 | 2 | C0032580 | |
| Disease | Nuclear non-senile cataract | 1.55e-03 | 18 | 96 | 2 | C1112705 | |
| Disease | Nuclear cataract | 1.55e-03 | 18 | 96 | 2 | C0392557 | |
| Disease | Pancreatic carcinoma | 1.73e-03 | 19 | 96 | 2 | C0235974 | |
| Disease | Retinitis pigmentosa | 1.83e-03 | 74 | 96 | 3 | cv:C0035334 | |
| Disease | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | 1.94e-03 | 398 | 96 | 6 | EFO_0003756, EFO_0003888, EFO_0004337 | |
| Disease | birth weight | 1.96e-03 | 399 | 96 | 6 | EFO_0004344 | |
| Disease | gastric ulcer | 2.11e-03 | 21 | 96 | 2 | EFO_0009454 | |
| Disease | Splenomegaly | 2.32e-03 | 22 | 96 | 2 | C0038002 | |
| Disease | Cardiomegaly | 2.45e-03 | 82 | 96 | 3 | C0018800 | |
| Disease | Cardiac Hypertrophy | 2.45e-03 | 82 | 96 | 3 | C1383860 | |
| Disease | neuroimaging measurement | APC ARHGEF12 RUNX1T1 LRCH1 TAOK2 FADS1 ZBTB32 MAPK6 AGAP1 AGAP3 | 2.52e-03 | 1069 | 96 | 10 | EFO_0004346 |
| Disease | BMI-adjusted fasting blood glucose measurement | 2.53e-03 | 23 | 96 | 2 | EFO_0008036 | |
| Disease | Dystonia | 2.81e-03 | 86 | 96 | 3 | C0013421 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YHPSLHDYMQNIHGK | 401 | Q96P47 | |
| HDYHDIIKHPMDLST | 346 | Q15059 | |
| HPSLHDYMQNVHGKE | 381 | Q9UPQ3 | |
| DMAHAVHPNYLDKHE | 356 | Q9ULA0 | |
| PKLIHYHQHNSAGMI | 371 | P51813 | |
| RLGYHAIPSMSHVHL | 261 | Q7Z2E3 | |
| VLPVMHESHHAQSEY | 331 | Q9BR77 | |
| PHVRHMAYQLCHALR | 406 | P49761 | |
| QHMRDSKHIVVYHRG | 326 | P50416 | |
| HNTPLHYAARHGMNK | 46 | Q9P2G1 | |
| AKAMALIHLSATHYH | 3086 | Q96M86 | |
| HRHYIQTMQERVHPE | 461 | Q9NZN5 | |
| LIRHQMSHDSGKHYE | 306 | Q03112 | |
| VHLQTPLHMAIAYNH | 541 | Q9P2R3 | |
| SHQDHLRKDPYANLM | 391 | Q86TB9 | |
| VMPLRASNFHYHELK | 861 | Q12791 | |
| HHPRVAKYAMENHSL | 506 | Q9NS87 | |
| NHEMYDYLLHGHRLK | 806 | Q12866 | |
| PPQHYRLDDMAIAHH | 296 | Q06455 | |
| RIMDPHYSHKGHLSE | 176 | Q16659 | |
| HLHPRSICMIQKYNH | 171 | Q9BUK6 | |
| SKHKNPYHNLMHAAD | 221 | Q14123 | |
| SHYGHNDDVRNHAMK | 661 | P16284 | |
| RHFELEKHSAPSMVH | 361 | Q16649 | |
| YLNHLEPPVKHMSFH | 151 | Q8TAT6 | |
| VHYLHSNMIVHRDIK | 471 | Q9Y2U5 | |
| AAFSANERPRHHHVM | 221 | Q8N5Y2 | |
| HAGAAYREVQKLMHH | 41 | Q03052 | |
| YLHTMERPHLHQHVE | 301 | Q9Y2L9 | |
| SHMLHMDPHQRYTAE | 661 | Q9UK32 | |
| DIAMAHHFRDAYRHP | 346 | O75081 | |
| RMVMAHLVNHLGHYP | 1376 | Q2PPJ7 | |
| LHYPQKHMRLFIHNH | 311 | Q02809 | |
| MLHFVMHGQHHKAPF | 251 | Q7L5A8 | |
| RQTEHDHYPESRMLH | 236 | Q8NCM8 | |
| EALKYHFMPEHRLSH | 256 | Q9NXS3 | |
| KQMLDHFQATPHHGV | 106 | Q86TI2 | |
| HHRPGSYLDMKIHLE | 36 | Q9P2H0 | |
| RHQLEMPGHYSHLAA | 176 | A4D1U4 | |
| HLFPTMPRHNYHKVA | 386 | O60427 | |
| IHKHGFFHRDMKPEN | 116 | P20794 | |
| GLDLRPHNHLQHYDM | 136 | Q8IYD2 | |
| RHVYEVPSGKHLMDH | 1846 | Q05BV3 | |
| SAKLYNGHHHLLMTE | 311 | Q9Y6H8 | |
| HRHREKYPHVQMNPH | 421 | Q9Y467 | |
| FNAHYNLTRHMPVHT | 286 | Q8TBJ5 | |
| SHHHHQPHKMDLKAY | 391 | Q9Y261 | |
| VRHDQDPGYMHHKFA | 146 | Q8N2A8 | |
| KALDYIHHMGYVHRS | 181 | Q7RTN6 | |
| IHHMGYVHRSVKASH | 186 | Q7RTN6 | |
| RNLHSHYHEAPMTRK | 421 | Q9UKY4 | |
| HYHEAPMTRKHYQVT | 426 | Q9UKY4 | |
| KHQFVMSRHHDKVPG | 1341 | Q6T4R5 | |
| LKATYHAHMVIHREN | 1031 | P57071 | |
| AHYNLTRHMPVHTGA | 271 | A0PJY2 | |
| VHLPHNYHIDFEIRM | 596 | Q9NYY8 | |
| LDDQGHIILHSMHKY | 226 | Q96SF7 | |
| HIILHSMHKYQPRVH | 231 | Q96SF7 | |
| AEHVRVMHANNPKYV | 581 | Q9BVL4 | |
| HLKQKYPHHASAIMG | 96 | Q5T5P2 | |
| YPHHASAIMGHQERL | 101 | Q5T5P2 | |
| YLHSHNMIHRDVKAG | 141 | Q9UL54 | |
| KTPMEMLYHHVHRLN | 866 | Q8IXF0 | |
| RSMEGHAPHHFKLVS | 76 | Q8TE99 | |
| LAETYPIHMHSQLDH | 616 | Q2Y0W8 | |
| LSDVHLYTPNHRHLM | 21 | Q9BUU2 | |
| YRHMATHSAQKPHQC | 86 | Q9UPG8 | |
| PADLAHKIHSANHMD | 1001 | P25054 | |
| PFATHYPNHLARHMK | 366 | Q8N8E2 | |
| YPNHLARHMKTHSGE | 371 | Q8N8E2 | |
| RHHRIHSMEKPYVCS | 286 | Q6P1L6 | |
| LHRHVNMYHNPEKPY | 561 | Q9ULJ3 | |
| TNHHRMHTGEQPYKC | 396 | Q6PDB4 | |
| FLHSYDLKNHMHLHT | 411 | O15156 | |
| DLKNHMHLHTGDRPY | 416 | O15156 | |
| HDAAFFLSRPMYAHH | 811 | Q8NI27 | |
| QHKQDPYIASMEHHT | 61 | Q8TAF3 | |
| PHHHYSAIERNNLMR | 1706 | Q9BX84 | |
| KVEAFEHRMYSHPLH | 796 | P42285 | |
| EHRMYSHPLHNDPNL | 801 | P42285 | |
| GHIILHSMHKYQPRV | 256 | O95935 | |
| LLHMHERTHTGEKPY | 211 | Q96GE5 | |
| GHLILHSMHKYQPRI | 206 | O95947 | |
| HSMHKYQPRIHLVRA | 211 | O95947 | |
| IMQLHHSKHHAAYVN | 46 | P04179 | |
| YMNKHGIVHRALSPH | 106 | Q8TEA7 | |
| HLIEHMRLHSGEKPY | 946 | P37275 | |
| YLMPHLNRHQKTHSG | 366 | Q9NZV7 | |
| LLQHHMIHTGERPYE | 246 | O43296 | |
| RSYLMQHHPIHTGEK | 271 | Q7Z398 | |
| HNYDLKNHMRIHTGV | 431 | A1YPR0 | |
| HLQIHMRVHTGEKPY | 101 | Q8N3J9 | |
| LLHMHERTHTGEKPY | 211 | Q9Y2A4 | |
| HHRIHTGEKPYQCSM | 416 | Q9BRR0 | |
| YGTEDHHKNLRNHMV | 91 | Q68EA5 | |
| MPLRDKYCQTDHHHH | 1 | Q2TB10 | |
| HQMETHYRVHTGEKP | 386 | Q9Y2Y4 | |
| HGHIILNSMHKYQPR | 216 | Q9UMR3 | |
| HLSRHMNSHVKEKPY | 226 | Q96LX8 | |
| AFNYSTHLKIHMRIH | 456 | Q9BUY5 | |
| SVSHLISYHMDNHLP | 551 | P29353 | |
| LHNHHRVHTGEMPYK | 331 | Q96NJ3 | |
| VFRHLENYANHLKMH | 281 | Q9HCK0 | |
| AFAHNYDLKNHMRVH | 446 | O95365 | |
| HRHERSHMGEKAYQC | 286 | Q8NDP4 | |
| DLVNEAKRYHMLPHA | 551 | Q96CT2 |